Bioasis Inks Second Research Pact with Univ. of British Columbia for p97-based Tech

The latest pact will focus on the use of p97 as a delivery system to transport Alzheimer's drugs across the blood-brain barrier. Last month, Bioasis and UBC inked a first research collaboration to develop and test a p97-based blood test to diagnose and monitor Alzheimer's.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.